Comprehensive medication guide to Mebendazole including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$5/fill with Emverm Savings Program for eligible commercially insured patients; copay varies by plan if covered without savings card. Prior authorization frequently required. Not covered by the Emverm Savings Program for Medicare/Medicaid patients.
Estimated Cash Pricing
$4,287–$5,258 retail for brand-name Emverm (2 tablets); with the Emverm Savings Program (commercial insurance required), cost can be as low as $5 per fill. No generic mebendazole is currently available in the US.
Medfinder Findability Score
42/100
Summarize with AI
On this page
Mebendazole is a broad-spectrum anthelmintic (anti-worm) medication belonging to the benzimidazole drug class. It was first developed in 1971 by Janssen Pharmaceutica in Belgium and received FDA approval in the United States in 1974. It is on the World Health Organization's List of Essential Medicines, reflecting its critical importance to global public health.
In the United States, mebendazole is available under the brand name Emverm (100 mg chewable tablet) manufactured by Amneal Pharmaceuticals. The original brand Vermox was discontinued around 2011, and no FDA-approved generic mebendazole is currently available on the US market. Mebendazole is FDA-approved to treat pinworm (Enterobius vermicularis), roundworm (Ascaris lumbricoides), hookworm (Ancylostoma duodenale and Necator americanus), and whipworm (Trichuris trichiura) in patients aged 2 years and older.
Off-label uses include capillariasis, toxocariasis, trichinellosis (Trichinella spiralis infection), cystic echinococcosis, and trichostrongyliasis. For tissue-invasive parasitic infections, albendazole is generally preferred due to better systemic absorption. Mebendazole is not a controlled substance and can be prescribed by any licensed healthcare provider including via telehealth.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Mebendazole works by binding to the colchicine binding site of beta-tubulin in parasitic worm cells. This blocks the polymerization of tubulin dimers, preventing the formation of microtubules — the structural scaffolding that worm cells depend on for nutrient uptake, cell division, and reproduction. Without functioning microtubules, the worm's intestinal cells can no longer absorb glucose, their primary energy source.
As glucose uptake halts, ATP production falls, and the worm's digestive and reproductive functions deteriorate. The parasite becomes immobilized, stops producing eggs, and dies gradually over the following days. Dead worms are then expelled from the body through normal bowel movements.
Mebendazole is poorly absorbed into the human bloodstream (less than 10% systemic absorption), which means it concentrates its activity within the digestive tract where intestinal parasites live. Human beta-tubulin also has a different structure from worm beta-tubulin, making mebendazole's binding highly selective for the parasite. This combination of selective binding and poor systemic absorption is why mebendazole can effectively kill intestinal worms with a minimal side effect profile at standard doses.
100 mg — chewable tablet
Single dose for pinworm; twice daily for 3 days for roundworm, hookworm, whipworm
500 mg — chewable tablet
Discontinued in the US (was Vermox). No longer commercially available in the United States.
As of 2026, mebendazole (Emverm) is not listed on the FDA Drug Shortage Database. However, many patients experience significant difficulty filling their prescriptions. The primary barrier is not supply — it's price and pharmacy stocking decisions. Emverm's retail price of $4,287–$5,258 for just 2 tablets leads many pharmacy chains to not stock it routinely, since demand is insufficient to justify carrying high-priced, low-volume inventory.
Independent community pharmacies, hospital outpatient pharmacies, and specialty pharmacies focused on infectious disease medications are more likely to carry Emverm or be able to order it within 1–3 business days. Large chain pharmacies often do not keep it in stock and may need to special-order it. Additionally, no generic version of mebendazole is currently available in the US, which means there is no lower-cost alternative form of the same active ingredient.
Rather than calling pharmacy after pharmacy, patients can use medfinder to locate pharmacies near them that have mebendazole in stock. medfinder calls pharmacies on your behalf and texts you the results, saving significant time and frustration.
Mebendazole is not a controlled substance and has no DEA scheduling restrictions. Any licensed prescriber in the United States can write a prescription for mebendazole without special registration, certification, or training. This makes access straightforward compared to controlled medications.
Mebendazole can also be prescribed via telehealth platforms without any special restrictions. This makes it easy to obtain quickly for straightforward cases like pinworm — telehealth services such as Teladoc, MDLive, and Sesame can connect patients with a licensed provider within hours who can evaluate and prescribe mebendazole if appropriate.
No. Mebendazole (Emverm) is not a controlled substance and is not scheduled by the DEA. It can be prescribed by any licensed healthcare provider — including primary care physicians, pediatricians, nurse practitioners, physician assistants, and urgent care providers — without any special registration or certification.
Because mebendazole is not a controlled substance, it can also be prescribed via telehealth without any additional restrictions that apply to scheduled medications. Prescriptions can be transmitted electronically (e-prescribe) to any licensed pharmacy. There are no refill quantity limits imposed by federal scheduling requirements, though individual insurance plans may limit the number of fills covered per year.
Mebendazole is generally well-tolerated, particularly with standard short-course therapy. The most commonly reported side effects are gastrointestinal:
Know what you need? Skip the search.
Albendazole (Albenza)
Same benzimidazole drug class; comparable efficacy for intestinal worms; better absorbed systemically (preferred for tissue-invasive infections). Generic available; as low as $37–$150 per course with discount cards.
Pyrantel Pamoate (Pin-X, Reese's Pinworm Medicine)
Over-the-counter antiparasitic effective for pinworm and hookworm. No prescription needed. Cost $8–$15 at most pharmacies. Paralyzes worms via different mechanism.
Ivermectin (Stromectol)
Prescription antiparasitic with different mechanism. Generic available. Primarily for strongyloidiasis; also effective for certain roundworm infections. Not indicated for pinworm or whipworm.
Praziquantel
Used for schistosomiasis, tapeworm infections. Different spectrum of activity than mebendazole — not a substitute for intestinal nematode infections.
Prefer Mebendazole? We can find it.
Metronidazole (Flagyl)
majorConcomitant use significantly increases risk of Stevens-Johnson syndrome and toxic epidermal necrolysis. Combination must be avoided.
Phenytoin (Dilantin)
majorInduces CYP450 metabolism of mebendazole, significantly reducing its serum levels and potentially reducing efficacy.
Fosphenytoin (Cerebyx)
majorConverted to phenytoin in the body; same interaction as phenytoin — reduces mebendazole levels.
Carbamazepine (Tegretol)
moderateCYP450 inducer that lowers serum mebendazole levels; may reduce treatment efficacy.
Deferiprone
majorAdditive risk of neutropenia and agranulocytosis; avoid concurrent use or monitor CBC closely.
Ropeginterferon alfa-2b
majorMyelosuppressive agents can produce additive myelosuppression. Avoid combination.
Cimetidine (Tagamet)
minorMay modestly inhibit mebendazole metabolism, potentially raising blood levels slightly.
Mebendazole (Emverm) is an effective, well-established antiparasitic medication that has been treating intestinal worm infections for over 50 years. Its greatest challenge in the United States is not clinical but economic: the absence of generic competition has resulted in retail prices that exceed $4,000 for a medication that costs cents per tablet in most of the world. The Emverm Savings Program is a critical resource for commercially insured patients, bringing costs down to as little as $5 per fill.
For patients who cannot afford Emverm or cannot access the savings program, effective alternatives exist — including generic albendazole (starting at ~$37 with discount cards) and pyrantel pamoate (available OTC for $8–$15 for pinworm). The key is not to delay treatment, as intestinal worm infections can spread to household members and cause ongoing health problems if left untreated.
If you've been prescribed mebendazole and are struggling to find it at your local pharmacy, medfinder can help. medfinder calls pharmacies near you to identify which ones have it in stock, and texts you the results — so you can skip the phone calls and head straight to the right pharmacy.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards